| FGF21 regulates sweet and alcohol preference S Talukdar, BM Owen, P Song, G Hernandez, Y Zhang, Y Zhou, WT Scott, ... Cell metabolism 23 (2), 344-349, 2016 | 326 | 2016 |
| Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice NK LeBrasseur, TM Schelhorn, BL Bernardo, PG Cosgrove, PM Loria, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2009 | 213 | 2009 |
| Glycolytic fast‐twitch muscle fiber restoration counters adverse age‐related changes in body composition and metabolism Y Akasaki, N Ouchi, Y Izumiya, BL Bernardo, NK LeBrasseur, K Walsh Aging cell 13 (1), 80-91, 2014 | 99 | 2014 |
| Postnatal PPARδ activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice BL Bernardo, TS Wachtmann, PG Cosgrove, M Kuhn, AC Opsahl, ... PLoS one 5 (6), e11307, 2010 | 79 | 2010 |
| Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin … Y Weng, JR Chabot, B Bernardo, Q Yan, Y Zhu, MB Brenner, C Vage, ... PloS one 10 (3), e0119104, 2015 | 69 | 2015 |
| FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance B Bernardo, M Lu, G Bandyopadhyay, P Li, Y Zhou, J Huang, N Levin, ... Scientific reports 5 (1), 11382, 2015 | 62 | 2015 |
| Glyco-engineered long acting FGF21 variant with optimal pharmaceutical and pharmacokinetic properties to enable weekly to twice monthly subcutaneous dosing Y Weng, T Ishino, A Sievers, S Talukdar, JR Chabot, A Tam, W Duan, ... Scientific Reports 8 (1), 4241, 2018 | 23 | 2018 |
| Characterization of cachexia in the human fibrosarcoma HT‐1080 mouse tumour model B Bernardo, S Joaquim, J Garren, M Boucher, C Houle, B LaCarubba, ... Journal of Cachexia, Sarcopenia and Muscle 11 (6), 1813-1829, 2020 | 15 | 2020 |
| Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acids JD Griffin, JM Buxton, JA Culver, R Barnes, EA Jordan, AR White, ... Molecular Metabolism 78, 101830, 2023 | 3 | 2023 |
| Is there a murine model that fully recapitulates human NASH? An unbiased bioinformatics approach to rank pre-clinical models based on proximity to human disease M Vacca, I Kamzolas, LM Harder, F Oakley, C Trautwein, M Hatting, ... Journal of Hepatology 77, S7-S8, 2022 | 1 | 2022 |
| COMPREHENSIVE CHARACTERIZATION OF AN OFF-THE-SHELF MODIFIED AMLN MOUSE MODEL AND CONSIDERATIONS FOR EXPERIMENTAL DESIGN TARGETING STEATOTIC, INFLAMMATORY AND FIBROTIC ENDPOINTS B Bernardo, R Barnes, M MacBride, J Richardson, TR Ross The Liver Meeting Digital Experience™, 2020 | | 2020 |
| 1901-P: CK1 δ/ε Inhibitor PF-05006739 Ameliorates Hepatic Steatosis and Hyperinsulinemia in Dio Mice M Peloquin, J Litchfield, BB Zhang, C Chang, RA Miller, B Bernardo, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| Development of a Hyperglycemic Clamp in Non-Human Primates to Assess GLP-1 Mediated Insulin Secretion BL Bernardo, DA Griffith, MS Landis, D Wanapun, DA Tess, TS Mcdonald, ... DIABETES 63, A451-A451, 2014 | | 2014 |
| A Small Molecule TGR5 (GPBAR1) Agonist Shows Metabolic and Anti-Inflammatory Effects in Cells Expressing Human TGR5 JE Chin, BL Bernardo, MB Brenner, J Buxton, JB Cheng, K Futatsugi, ... DIABETES 62, A525-A525, 2013 | | 2013 |
| Fibroblast growth factor-21 (FGF-21) synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes MB Brenner, DV Lee, B Bernardo, S Talukdar DIABETOLOGIA 55, S226-S226, 2012 | | 2012 |
| Activin E Mediates Liver-Adipose Inter-Organ Communication, Suppressing Adipose Lipolysis to Regulate Hepatic Triglyceride JD Griffin, J Buxton, JA Culver, R Barnes, EA Jordan, AR White, ... Suppressing Adipose Lipolysis to Regulate Hepatic Triglyceride, 0 | | |
